Revvity (RVTY) Total Current Liabilities (2010 - 2026)
Revvity's (RVTY) quarterly Total Current Liabilities came in at $1.3 billion in Q3 2026, up 89.99% on a YoY basis from $671.8 million in Q3 2025, and up 3.04% quarter-over-quarter from $1.2 billion in Q2 2026.
Analysis
Revvity (RVTY) Total Current Liabilities (2010 - 2026) Analysis & Trends
Revvity (RVTY) has reported Total Current Liabilities for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Total Current Liabilities rose 89.99% year-over-year to $1.3 billion; the trailing twelve-month figure through Jul 2026 stood at $1.3 billion (up 89.99% YoY), and the FY2025 full-year result was $1.3 billion, up 103.83% from the prior year.
- Total Current Liabilities grew to $1.3 billion in Q3 2026 per RVTY's latest filing, from $1.2 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.6 billion in Q2 2023 and bottomed at $648.2 million in Q1 2025.
- Historically, Total Current Liabilities has averaged $1.2 billion across 5 years, with a median of $1.3 billion in 2026.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities sank 54.97% in 2024, then soared 103.83% in 2025.
- Over 5 years, Total Current Liabilities stood at $1.5 billion in 2022, then dropped by 2.37% to $1.5 billion in 2023, then tumbled by 54.97% to $653.1 million in 2024, then surged by 103.83% to $1.3 billion in 2025, then dropped by 4.12% to $1.3 billion in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.3 billion, $1.2 billion, and $1.3 billion for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 15.07 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 8.11 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 2.29 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 1.58 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 1.28 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 163.70 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 961.30 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 132.66 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 118.51 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 1.20 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 1.28 Bn |
| Apr 5, 2026 | 1.24 Bn |
| Dec 28, 2025 | 1.33 Bn |
| Sep 28, 2025 | 1.22 Bn |
| Jun 29, 2025 | 671.81 Mn |
| Mar 30, 2025 | 648.19 Mn |
| Dec 29, 2024 | 653.10 Mn |
| Sep 29, 2024 | 687.94 Mn |
| Jun 30, 2024 | 1.39 Bn |
| Mar 31, 2024 | 1.37 Bn |
| Dec 31, 2023 | 1.45 Bn |
| Oct 1, 2023 | 1.45 Bn |
| Jul 2, 2023 | 1.37 Bn |
| Apr 2, 2023 | 1.56 Bn |
| Jan 1, 2023 | 1.54 Bn |
| Oct 2, 2022 | 1.49 Bn |
| Jul 3, 2022 | 1.04 Bn |
| Apr 3, 2022 | 1.26 Bn |
| Jan 2, 2022 | 1.21 Bn |
| Oct 3, 2021 | 1.15 Bn |